MEDP · Medpace Holdings, Inc.
$585.49
+14.52 (+2.54%)
At close · Jul 29
Market Cap
$15.94B
Shares
27.91M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$2,100,000,000
as of 2025-06-30
Remaining Authorization
$527,000,000
as of 2026-06-30
Program Utilization
74.9%
$1,573,000,000 used of $2,100,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-06-30 YTD | $294,764,000 | 10-Q, filed 2026-07-23 | ||
| 2025-12-31 | $917,389,000 | 10-K, filed 2026-02-10 | ||
| 2024-12-31 | $169,867,000 | 10-K, filed 2026-02-10 | ||
| 2023-12-31 | $144,020,000 | 10-K, filed 2026-02-10 | ||
| 2022-12-31 | $847,849,000 | 10-K, filed 2025-02-11 | ||
| 2021-12-31 | $62,096,000 | 10-K, filed 2024-02-13 | ||
| 2020-12-31 | $98,274,000 | 10-K, filed 2023-02-14 | ||
| 2019-12-31 | $0 | 10-K, filed 2022-02-15 | ||
| 2018-12-31 | $0 | 10-K, filed 2021-02-16 | ||
| 2017-12-31 | $155,583,000 | 10-K, filed 2020-02-25 | ||
Key facts
CIK
1668397
CUSIP
58506Q109
13F (30d)
190 filings
189 filers
Visit website
Investor relations